Company Luoxin Pharmaceuticals Group Stock Co., Ltd.

002793

CNE1000026S7

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
5.06 ^CNY	+3.69%		+5.20%	-5.60%

04-26	Luoxin Pharmaceuticals Group Stock Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-08	Luoxin Pharma Gets Right to Use Shenzhen Shishijijun Biotechnology's Fecal Microbiota Transplant Technology	MT

Luoxin Pharmaceuticals Group Stock Co Ltd, formerly Zhejiang Doyin Pump Industry Co Ltd, is a China-based company mainly engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company operates two segments. The Pharmaceutical Industry segment is engaged in the research and development, manufacturing and sales of chemical drug preparations and raw and auxiliary drugs. Its main products are digestive drugs, respiratory drugs and antibiotic drugs, among others. The Pharmaceutical Business segment is engaged in the sales and logistics of agent drugs and medical devices. The Company conducts its businesses in the domestic market.

Number of employees: 4,582

Managers	Title	Age	Since
Zhen Teng Liu CEO	Chief Executive Officer	38	22/04/20
Xian Chen DFI	Director of Finance/CFO	41	07/07/21
Hong Yan Liu BRD	Director/Board Member	42	30/01/23
Meng Li BRD	Director/Board Member	47	26/04/21
Xue Yun Zhu IRC	Investor Relations Contact	-	-
Feng Sheng Han SEC	Corporate Secretary	49	22/04/20

Members of the board	Title	Age	Since
Feng Sheng Han SEC	Corporate Secretary	49	22/04/20
Liang Wei Song CHM	Chairman	44	30/01/23
Yun Pei Guo BRD	Director/Board Member	76	18/05/21
Zhi Ang Wu BRD	Director/Board Member	58	22/04/20
Zhen Fei Liu BRD	Director/Board Member	36	31/03/11
Zhen Teng Liu CEO	Chief Executive Officer	38	22/04/20
Xia Xu BRD	Director/Board Member	52	22/04/20
Meng Li BRD	Director/Board Member	47	26/04/21
Fang Xia BRD	Director/Board Member	35	30/01/23
Hong Yan Liu BRD	Director/Board Member	42	30/01/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,087,588,486	601,119,890 ( 55.27 %)	0	55.27 %

Name	Equities	%	Valuation
Xiu Bao Fang 18.56 %	110,736,346	18.56 %	71 M ¥
Deyi (Zhuhai) Capital Management Co. Ltd. 17.17 %	102,443,530	17.17 %	65 M ¥
Bin Zhang 5.874 %	35,050,459	5.874 %	22 M ¥
Lai Yang Chen 5.874 %	35,050,458	5.874 %	22 M ¥
Maui Jue Zhi La 5.765 %	34,400,000	5.765 %	22 M ¥
Dong Hui Fang 3.500 %	20,884,500	3.500 %	13 M ¥
Qianhai Fangzhou Asset Management Co. Ltd. 3.345 %	19,960,758	3.345 %	13 M ¥
SHANDONG LUOXIN HOLDINGS CO LTD 3.184 %	19,000,000	3.184 %	12 M ¥
Ally Bridge Group HK Ltd 3.047 %	18,185,013	3.047 %	12 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD. 2.809 %	16,759,622	2.809 %	11 M ¥

Name	Equities	%	Valuation
Bao Qi Liu 53.14 %	260,846,120	53.14 %	167 M ¥
Ally Bridge Group HK Ltd 11.16 %	54,759,382	11.16 %	35 M ¥
Shanghai Juezhi Investment Management Co. Ltd. 7.696 %	37,776,218	7.696 %	24 M ¥
Lai Yang Chen 3.766 %	18,484,216	3.766 %	12 M ¥
Bin Zhang 3.766 %	18,484,216	3.766 %	12 M ¥
Deyi (Zhuhai) Capital Management Co. Ltd. 2.168 %	10,640,378	2.168 %	7 M ¥
Qianhai Fangzhou Asset Management Co. Ltd. 2.145 %	10,526,509	2.145 %	7 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD. 1.797 %	8,822,537	1.797 %	6 M ¥
Hai Feng Hou 1.358 %	6,663,480	1.358 %	4 M ¥
Feng Xu 1.164 %	5,715,227	1.164 %	4 M ¥

Luoxin Pharmaceuticals Group Stock Co., Ltd.

Building 4 18, Luoqi Road

276017, Linyi

http://www.luoxin.cn

address Luoxin Pharmaceuticals Group Stock Co., Ltd.(002793)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.	-5.60%	734M
NOVO NORDISK A/S	+31.37%	588B
JOHNSON & JOHNSON	-2.60%	364B
MERCK & CO., INC.	+20.83%	326B
ABBVIE INC.	+5.69%	285B
ASTRAZENECA PLC	+14.83%	239B
NOVARTIS AG	+9.93%	210B
ROCHE HOLDING AG	-6.95%	200B
AMGEN INC.	+10.77%	167B
PFIZER, INC.	+0.10%	161B